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Discussion/Conclusion: We conclude that it is feasible to apply two phase‑
inverted adiabatic‑half‑passage pulses for 13C excitation to achieve a flatter‑
phase‑response to off‑resonance, and this will allow further extension of this 
technique for 13C‑MRS measurements such as in human brain.
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Purpose/Introduction: Non‑negative matrix factorization (NMF) [1] is hi‑
erarchically applied to in vivo three‑dimensional 3T MRSI prostate data to 
automatically extract characteristic patterns for tumour and benign tissue, 
and to visualize their spatial distribution.
Subjects and Methods: NMF is a blind source separation technique impos‑
ing non‑negative constraints on the extracted sources and corresponding 
weights. Specifically, given a non‑negative matrix XͼRmxn, and an integer k 
(0<k<min(m,n)), two non‑negative matrices WͼRmxk and HͼRkxn, minimizing 
the functional f(W,H)=0.5(║X-WH║F)2, are estimated. Here, NMF is embed‑
ded into a hierarchical scheme (HNMF) by setting k=2 at each step:
Step1) NMF is applied to the dataset X, containing spectra as columns: two 
patterns (W columns) and corresponding weights (H rows) are obtained. 
Signals are divided into two new datasets based on the maximum weight value.
Step2) NMF is applied to each dataset obtained in Step1 and, as above, signals 
are divided into four datasets. Similarly, one more NMF step is performed, 
thereby providing eight patterns. The two most correlated patterns with given 
theoretical models for tumour and benign tissue are selected.
Step3) non‑negative least squares (NNLS) [2] is applied to X by using the 
final patterns of Step2. Two coefficient vectors are obtained which, reshaped 
and encoded as color channels in an RGB image, provide a visualization of 
the pathological area.
Results: HNMF is applied to an in vivo 3T 16x16x16 MRSI dataset measured 
by a Siemens Magnetom Trio scanner (TE=145ms, TR=790ms, voxel size: 
6mmx6mmx6mm, signal length: 512 data points). Based on histopathology, 
the tumor is located on the left‑hand side of the prostate (Fig.1).
Fig.2
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and Fig.3 
show the tumor and benign patterns provided by Step1 and Step2, respec‑
tively, along with their correlation coefficients with the theoretical models. 
Such values show that Step2 provides the most correlated patterns with the 
given models. Fig.4 
and Fig.5 
show the results of Step3 for one slice by exploiting the HNMF patterns and 
the theoretical models, respectively. In Fig.4 the pathological region is more 
enhanced than in Fig.5. The required HNMF computational time is 2.1s.
Discussion/Conclusion: HNMF is applied to in vivo MRSI data to detect 
prostate tumours. Our study shows that, potentially, HNMF is efficient and 
accurate, and provides higher quality results than applying NNLS directly 
with theoretical models. Indeed, HNMF is able to adapt the given models 
to the specific patient dataset and, therefore, to describe its spectral content 
more appropriately.
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Purpose/Introduction: The potential ergogenic effect of oral administration of 
salbutamol on exercise performance has been demonstrated for decades (1) but 
the underlying mechanisms are not completely elucidated (2). We hypothesized 
that an acute oral dose of salbutamol may improve muscle metabolism and 
increase endurance during a localized exercise in moderately trained subjects.
Subjects and Methods: Twelve healthy, non‑asthmatic, physically active, male 
subjects were recruited to compare in a double‑blinded crossover randomized 
study an oral dose of salbutamol (4mg) and a placebo intake before a calf fatigue 
test. Subjects were requested to perform plantar flexions against a progressively 
increasing resistance at a frequency of 0.5 Hz (maintained with the aid of a 
visual feedback and a rhythmic soundtrack) until exhaustion in the magnet. A 
continuous 31P NMRS assessment was performed for 2 min at baseline before 
the exercise, during the exercise and during the recovery period.
Results: No significant difference was detected in metabolites concentra‑
tion (PCr, Pi/PCr, ADP and ATP) at baseline, during exercise and during 
the recovery period (p>0.05). The oxidative potential indicated by the PCr 
resynthesis after the end of the exercise was not modified (tPCr: 38 ±8 and 
39 ±9 s for salbutamol and placebo respectively; p=0.80). However, while the 
intracellular pH (pHi) was not significantly different at rest with salbutamol 
compared to placebo (p=0.43), the decrease in pHi values was significantly 
lower with salbutamol than placebo during the incremental test (deltapHi: ‑0.09 
vs. ‑0.19 for salbutamol and placebo respectively; p=0.018). Moreover, the Pmax 
(28 ±7 W vs. 23 ±7 W for salbutamol and placebo, respectively; p < 0.001) 
and the total work performed (1702 ±442 J vs. 1381 ±432 J respectively; p < 
0.001) during the incremental test were significantly increased with salbutamol 
compared to placebo.
Discussion/Conclusion: 
Oral administration of salbutamol induced significant improvement in calf 
muscle endurance with similar metabolic responses in moderately trained 
sportsmen, except small changes in pHi. These results suggest that mechanisms 
beyond the muscle (e.g. at the CNS level) may account for the increase exercise 
performance with oral salbutamol intake.
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